<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04157790</url>
  </required_header>
  <id_info>
    <org_study_id>49RC19_0071</org_study_id>
    <nct_id>NCT04157790</nct_id>
  </id_info>
  <brief_title>Efficacy of the CARE Rule Associated With the HEART Score in Patients With Emergency Chest Pain</brief_title>
  <acronym>e-CARE</acronym>
  <official_title>Efficacy of the CARE Rule Associated With the HEART Score in Patients With Emergency Chest Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Angers</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Angers</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Acute coronary syndrome (ACS) is a major public health problem and its diagnosis remains a
      challenge for the emergency physician. The European Society of Cardiology recommends a
      troponin dosage and renew it if necessary during any suspicion of ACS. However, the criteria
      leading to initiate a diagnostic procedure during chest pain are imprecise. The fear is, on
      the one hand, to miss a potentially vital diagnosis and, on the other hand, to expose a large
      number of patients to unnecessary examinations.

      The CARE rule (also known as HEAR score) seems to streamline this first step. It assigns a
      value of 0 to 2 using 4 items: Characteristic of pain, Age, Risk factors and
      Electrocardiogram (ECG). The search for an ACS is not justified if the sum of the points is
      &lt;2 (negative rule) and, inversely, a troponin determination must be carried out if the sum is
      &gt; 1 (positive rule).

      The aim of the study is to demonstrate the safety and interest of the CARE rule associated
      with the HEART score to streamline ACS's diagnostic approach to thoracic pain in emergencies
      departments.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2020</start_date>
  <completion_date type="Anticipated">July 2021</completion_date>
  <primary_completion_date type="Anticipated">July 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Sequential Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of major cardiac events</measure>
    <time_frame>30 days</time_frame>
    <description>Myocardial infarction, percutaneous or surgical coronary reperfusion, certain or potential cardiac death, or surviving cardiac arrest</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of major cardiac events for the intention to treat study population</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of troponin assays in the intention to treat population</measure>
    <time_frame>2 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time spent in the emergency department in the intention to treat population</measure>
    <time_frame>2 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">2080</enrollment>
  <condition>Chest Pain</condition>
  <arm_group>
    <arm_group_label>Neutral</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Suggested to follow European Society of Cardiology guidelines for NSTEMI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>CARE score</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>calculation of the CARE score and prescription for troponins assays or not according to the result (score &gt; 1: troponins assays ; score &lt; 2: no troponins assays)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>CARE score</intervention_name>
    <description>CARE score calculation</description>
    <arm_group_label>CARE score</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Admission to an Emergency Department participating in the study

          -  Non-traumatic chest pain

          -  Age greater than or equal to 18 years

          -  Patient's consent (oral for France, written for Belgium)

        Exclusion Criteria:

          -  30 days follow-up not possible

          -  ST-segment Elevation Myocardial Infarction (STEMI) on admittance ECG

          -  Chest pain formally reported to a diagnosis other than an ACS before inclusion (e.g.,
             pneumothorax, pleurisy, etc.)

          -  Troponin assay performed prior to inclusion (less than 24 hours old)

          -  Patient referred by another care structure (excluding primary medicine)

          -  Patient already included in study still in follow-up period

          -  Pregnant, breastfeeding or parturient patient,

          -  Patient deprived of liberty by judicial or administrative decision,

          -  Patient undergoing psychiatric care under duress,

          -  Patient subject to a legal protection measure,

          -  Patient unable to give free and informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Thomas MOUMNEH, MD</last_name>
    <phone>0241356650</phone>
    <phone_ext>+33</phone_ext>
    <email>thomas.moumneh@chu-angers.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Béatrice GABLE</last_name>
    <phone>0241356825</phone>
    <phone_ext>+33</phone_ext>
    <email>begable@chu-angers.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cliniques Universitaires Saint-Luc</name>
      <address>
        <city>Bruxelles</city>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Andréa PENALOZA, MD, PhD</last_name>
      <email>andrea.penaloza@uclouvain.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Liège</name>
      <address>
        <city>Liège</city>
        <country>Belgium</country>
      </address>
    </facility>
    <contact>
      <last_name>Alexandre GHUYSEN, MD, PhD</last_name>
      <email>a.ghuysen@chuliege.be</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Angers</name>
      <address>
        <city>Angers</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Thomas MOUMNEH, MD</last_name>
      <email>thomas.moumneh@chu-angers.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier de Cholet</name>
      <address>
        <city>Cholet</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Laure BAUDIN, MD</last_name>
      <email>laure.baudin@ch-cholet.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH Le Mans</name>
      <address>
        <city>Le Mans</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Thibault SCHOTTE, MD</last_name>
      <email>tschotte@ch-lemans.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Universitaire de Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Louis SOULAT, MD, PhD</last_name>
      <email>louis.soulat@chu-rennes.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Saint-Brieuc</name>
      <address>
        <city>Saint-Brieuc</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Christian BRICE, MD</last_name>
      <email>christian.brice@ch-stbrieuc.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CH de Saint-Malo</name>
      <address>
        <city>Saint-Malo</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Sabrina PERNET, MD</last_name>
      <email>s.pernet@ch-stmalo.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU Toulouse</name>
      <address>
        <city>Toulouse</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Sandrine CHARPENTIER, MD, PhD</last_name>
      <email>charpentier.s@chu-toulouse.fr</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHU de Tours</name>
      <address>
        <city>Tours</city>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Saïd LARIBI, MD, PhD</last_name>
      <email>s.laribi@chu-tours.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>Belgium</country>
    <country>France</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 5, 2019</study_first_submitted>
  <study_first_submitted_qc>November 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 8, 2019</study_first_posted>
  <last_update_submitted>November 6, 2019</last_update_submitted>
  <last_update_submitted_qc>November 6, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 8, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Emergencies</mesh_term>
    <mesh_term>Chest Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

